AINDEX
Markets

Envoy Medical, Inc. (COCH)

COCHNASDAQ-CMIndustrial Specialties

$6.81

-0.1600 (-2.30%) today

At the close, Nov 12, 4:00 PM ET. After hours $6.81 –

-2.30% 1D
Market cap
$52.74m
P/E
–
EPS, last 4 quarters
$-4.90
Dividend yield
–
Day range
$6.81 to $6.91
52-week range
$3.63 to $9.54
Average volume
–
Previous close
$6.97

Analysts

2 covering

Buy2 buy, 0 hold, 0 sell

Targets a year out average $21.50, +215.7% from here

$18.00now $6.81$25.00

Earnings

next estimate $-0.6400

Next report

Dec 2025

–

Mar 2026

+21.4%

Jun 2026

+22.2%

Sep 2026

+28.6%

estimate reported, and the surprise

Financials

QuarterSep 2025Dec 2025Mar 2026Jun 2026
Revenue$42.0k$75.0k$39.0k$51.0k
Gross profit-$161.0k-$136.0k-$274.0k-$227.0k
Operating income-$5.71m-$6.38m-$5.96m-$5.57m
Net income-$6.48m-$6.59m-$4.35m-$5.98m

Last four quarters: revenue $207.0k, margin -11304.8%, free cash flow –

News

8 latest

The company

Envoy Medical (NASDAQ: COCH) is a hearing health and neuroprosthetics company focused on providing innovative technologies across the hearing loss spectrum. Envoy Medical has pioneered one-of-a-kind, fully implanted devices for hearing loss, including its fully implanted Esteem active middle ear implant, commercially available in the U.S . since 2010, and the fully implanted Acclaim cochlear implant, an investigational device. Envoy Medical is dedicated to pushing hearing technology beyond the status quo to improve access, usability, compliance, and ultimately quality of life.

Sector
Health Care
Industry
Industrial Specialties
Exchange
NASDAQ-CM
Region
North America

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.